Displaying 1 - 50 of 65 results
Released Company Title Industry Topic
08 Mar 2024
07:00 CET
MITHRA Mithra reports full year 2023 financial results 20103015 Pharmaceuticals -
05 Mar 2024
07:01 CET
MITHRA Mithra announces changes to its executive management 20103015 Pharmaceuticals -
05 Mar 2024
07:00 CET
MITHRA Mithra initiates monetization process, receives bridge loan from existing lenders 20103015 Pharmaceuticals -
29 Feb 2024
11:42 CET
MITHRA DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase 20103015 Pharmaceuticals -
15 Feb 2024
18:23 CET
MITHRA Mithra sells shares in Mayne Pharma 20103015 Pharmaceuticals -
06 Feb 2024
07:00 CET
MITHRA Mithra updates on cash position 20103015 Pharmaceuticals -
21 Dec 2023
17:45 CET
MITHRA Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel 20103015 Pharmaceuticals -
20 Dec 2023
17:45 CET
MITHRA Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients 20103015 Pharmaceuticals -
18 Dec 2023
07:00 CET
MITHRA Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial 20103015 Pharmaceuticals -
04 Dec 2023
07:00 CET
MITHRA Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China 20103015 Pharmaceuticals -
30 Nov 2023
07:00 CET
MITHRA Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States 20103015 Pharmaceuticals -
28 Nov 2023
17:45 CET
MITHRA Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam 20103015 Pharmaceuticals -
07 Nov 2023
07:00 CET
MITHRA Mithra’s NEXTSTELLIS® granted additional patent in the United States 20103015 Pharmaceuticals -
06 Nov 2023
18:52 CET
MITHRA Mithra releases invitation to its extraordinary securities holders’ meeting 20103015 Pharmaceuticals -
26 Oct 2023
07:00 CEST
MITHRA Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada 20103015 Pharmaceuticals -
23 Oct 2023
07:00 CEST
MITHRA Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement 20103015 Pharmaceuticals -
17 Oct 2023
07:00 CEST
MITHRA Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting 20103015 Pharmaceuticals -
11 Oct 2023
07:15 CEST
MITHRA Shareholder Letter 20103015 Pharmaceuticals -
11 Oct 2023
07:00 CEST
MITHRA Mithra announces update to the agenda of its upcoming special general shareholders’ meeting 20103015 Pharmaceuticals -
10 Oct 2023
18:00 CEST
MITHRA Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress 20103015 Pharmaceuticals -
05 Oct 2023
07:00 CEST
MITHRA Mithra Provides an Update in the Context of Recent Market Developments 20103015 Pharmaceuticals -
28 Sep 2023
09:45 CEST
MITHRA Mithra prices private placement to raise EUR 20 million in equity 20103015 Pharmaceuticals Corporate life
28 Sep 2023
09:42 CEST
MITHRA Mithra Financial Results for First-Half 2023 20103015 Pharmaceuticals Commercial results
27 Sep 2023
07:00 CEST
MITHRA Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023 20103015 Pharmaceuticals -
26 Sep 2023
07:00 CEST
MITHRA Mithra Financial Results for First-Half 2023 20103015 Pharmaceuticals -
22 Sep 2023
13:30 CEST
MITHRA Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET 20103015 Pharmaceuticals -
21 Sep 2023
17:55 CEST
MITHRA Information on the total number of voting rights (denominator) 20103015 Pharmaceuticals -
21 Sep 2023
17:55 CEST
MITHRA Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST 20103015 Pharmaceuticals -
12 Sep 2023
17:45 CEST
MITHRA Publication of a Transparency Notification Received from Armistice Capital, LLC 20103015 Pharmaceuticals -
12 Sep 2023
17:45 CEST
MITHRA Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 20103015 Pharmaceuticals -
11 Sep 2023
07:30 CEST
MITHRA Letter to Shareholders and Corporate Update 20103015 Pharmaceuticals -
28 Aug 2023
17:45 CEST
MITHRA Mithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator) 20103015 Pharmaceuticals -
24 Aug 2023
07:33 CEST
MITHRA Mithra prices private placement to raise EUR 20 million in equity 20103015 Pharmaceuticals -
16 Jun 2023
08:55 CEST
MITHRA Mithra Announces Sale of Shares in Mayne Pharma 20103015 Pharmaceuticals Other financial transaction
25 Apr 2023
16:06 CEST
MITHRA Mithra Releases Invitation to its General Shareholders’ Meeting 20103015 Pharmaceuticals General meeting / Board Meeting
18 Apr 2023
11:16 CEST
MITHRA Mithra releases 2022 Annual Report 20103015 Pharmaceuticals Corporate life
27 Sep 2022
09:40 CEST
MITHRA Mithra 2022 Half Year Results 20103015 Pharmaceuticals Commercial results
17 Aug 2022
16:10 CEST
MITHRA Mithra obtains funding for up to EUR 100 Million from existing investors and repurchases EUR 34.1 million of its convertible bonds due 2025 at a discount to par 20103015 Pharmaceuticals Other financial transaction
17 Aug 2022
15:39 CEST
MITHRA Mithra Completes a EUR 23.5 Million Private Placement 20103015 Pharmaceuticals Change in Capital
17 Aug 2022
15:31 CEST
MITHRA Mithra 2021 Full Year Results 20103015 Pharmaceuticals Commercial results
17 Aug 2022
15:22 CEST
MITHRA Mithra résultats semestriels 2021 20103015 Pharmaceuticals Commercial results
17 Aug 2022
15:18 CEST
MITHRA Mithra 2021 Half Year Results 20103015 Pharmaceuticals Commercial results
09 Mar 2021
07:54 CET
MITHRA Mithra annonce ses résultats annuels 2020 20103015 Pharmaceuticals Commercial results
09 Mar 2021
07:52 CET
MITHRA Mithra Reports Full Year 2020 Financial Results 20103015 Pharmaceuticals Commercial results
21 Jan 2021
15:30 CET
MITHRA Mithra announces placement of EUR 125 million convertible bonds due 2025 20103015 Pharmaceuticals Other financial transaction
21 Jan 2021
15:26 CET
MITHRA First Half 2020 financial report 20103015 Pharmaceuticals Corporate life
18 Jun 2020
20:45 CEST
MITHRA Mithra Successfully Raises EUR 65.0 Million By Means of a Private Placement via an Accelerated Bookbuild Offering 20103015 Pharmaceuticals Change in Capital
18 Jun 2020
14:39 CEST
MITHRA Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy 20103015 Pharmaceuticals Change in Capital
09 Mar 2020
07:30 CET
MITHRA Mithra Reports Full Year 2019 Financial Results Pharmaceuticals Corporate life
09 Mar 2020
07:30 CET
MITHRA Mithra annonce ses résultats annuels 2019 Pharmaceuticals Corporate life